Neuroscience
| 10+ min read
Once symptoms show up, it’s too late to cure many autoimmune diseases. Researchers are investigating ways to prevent the conditions from starting at all.
| 2 min read
Dopamine stimulators may lessen the systemic side effects — often weight gain and diabetes — of dopamine-blocking antipsychotics.
| 10+ min read
No pharmaceutical treatments exist for addictions to drugs like cocaine or cannabis. Now, scientists are engineering gene therapies, immunotherapies, and more.
| 4 min read
Scientists recovered movement in mouse models of spinal cord injury.
| 5 min read
Scientists imaged new communication pathways between the skull and the brain and uncovered immune responses exclusive to the skull.
| 10+ min read
A new type of drug for schizophrenia could finally be approved in September. Others may not be far behind.
| 2 min read
Researchers discovered an immunological connection between the eye and the brain that could lead to new therapeutics for central nervous system diseases.
| 10 min read
People with achromatopsia have never seen color. Restorative gene therapies have had mixed success, leaving researchers wondering why.
| 4 min read
Researchers discovered that a cytokine surge during mid-gestation in mice influenced anxiety behavior in offspring.
| 7 min read
Researchers target the gut to see if they can treat depression with fewer side effects and less stigma than current drugs.
| 3 min read
In rheumatoid arthritis, damaged joints contain fibroblasts that prompt nerve cell growth, potentially causing pain even in the absence of inflammation.
| 3 min read
Targeting α-synuclein mRNA before it had a chance to aggregate reduced its protein levels in cultured dopaminergic neurons and may protect neurons.
